Further exploration of the molecular mechanisms of MITF and its interaction with downstream effectors could provide valuable insights into GIST pathobiology and guide the development of novel therapeutic strategies targeting MITF. This evidence concerns the gene MITF and gastrointestinal stromal tumor.